| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.005 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
| mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
| mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |